# Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

> **NCT03162198** · — · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 53 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Cirrhosis with HCC
- **OTHER:** Cirrhosis without HCC

## Key facts

- **NCT ID:** NCT03162198
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2019-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162198, "Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03162198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*